Results of Annual General Meeting

Advanced Medical Solutions Grp PLC

31 May 2023

 

31 May 2023

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Results of Annual General Meeting

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that at the Company's Annual General Meeting held today at 11 am at the Offices of Investec Bank plc, 30 Gresham Street, London, EC2V 7QP, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 28 April 2023.

The poll results were as follows.

Resolution	Title	For	For %	Against	Against %	Total Votes	% Issued Capital
1	FINANCIAL STATEMENTS	135,930,178	100.00%	2,600	0.00%	135,932,778	62.61%
2	REMUNERATION REPORT	134,448,331	98.78%	1,660,110	1.22%	136,108,441	62.69%
3	AUDITOR REMUNERATION	129,945,308	95.88%	5,579,727	4.12%	135,525,035	62.42%
4	RE-ELECT P ALLEN	121,131,315	88.99%	14,989,308	11.01%	136,120,623	62.70%
5	RE-ELECT G COOK	123,309,347	90.59%	12,804,964	9.41%	136,114,311	62.69%
6	RE-ELECT D LE FORT	123,977,756	91.08%	12,136,555	8.92%	136,114,311	62.69%
7	ELECT L SHANAHAN	136,068,717	99.97%	45,594	0.03%	136,114,311	62.69%
8	RE-ELECT C MEREDITH	131,687,725	96.74%	4,434,124	3.26%	136,121,849	62.70%
9	RE-ELECT E JOHNSON	133,113,126	97.80%	3,001,185	2.20%	136,114,311	62.69%
10	FINAL DIVIDEND	136,127,581	100.00%	278	0.00%	136,127,859	62.70%
11	ALLOT SHARES*	135,448,934	99.52%	654,222	0.48%	136,103,156	62.69%
12	PRE-EMPTION RIGHTS*	129,949,465	95.47%	6,165,524	4.53%	136,114,989	62.69%
13	PURCHASE SHARES*	135,042,435	99.95%	63,012	0.05%	135,105,447	62.23%

*  Special Resolution

Notes: 1.  Votes "For" and "Against" are expressed as a percentage of votes received. 2.  A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution. 3.  Total number of shares in issue at close of business on 26 May = 217,109,419 shares. 62.63% of the voting capital was instructed.

- Ends -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc	Tel: [phone]
Chris Meredith, Chief Executive Officer Eddie Johnson, Chief Financial Officer Michael King, Investor Relations
Consilium Strategic Communications	Tel: [phone]
Matthew Neal / Lucy Featherstone	[e-mail]
Investec Bank PLC (NOMAD & Broker)	Tel: [phone]
Gary Clarence / David Anderson
HSBC Bank PLC (Broker)	Tel: [phone]
Sam McLennan / Joe Weaving / Stephanie Cornish

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand^®, RESORBA^®, LiquiBandFix8^® and Seal-G^®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal^® brand as well as under white label. Since 2019, the Group has made five acquisitions: Sealantis, an Israeli developer of innovative internal sealants; Biomatlante, a French developer and manufacturer of surgical biomaterials, Raleigh, a leading UK coater and converter of woundcare and bio-diagnostics materials, AFS Medical, an Austrian specialist surgical business and Connexicon, an Irish tissue adhesives specialist.

AMS's products, manufactured in the UK, Germany, France, the Netherlands, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Austria, Germany, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Ireland, Germany, France and Israel. Established in 1991, the Group has more than 800 employees. For more information, please see www.admedsol.com.

 

END